Hygromycin b
Hygromycin B is a broad-spectrum antibiotic used as a selective agent in molecular biology applications. It inhibits protein synthesis in both prokaryotic and eukaryotic cells, making it effective for selection of recombinant cells and organisms.
Lab products found in correlation
15 protocols using hygromycin b
Lentiviral Transduction of CSRP2 in BV173 and Ramos Cells
RFP-Pb2 Transgenic Plant Root Analysis
Cellular Uptake Assay of Fluorescent Probe
Fusarium oxysporum Protoplast Preparation and Transformation
Genetic Manipulation of Botrytis cinerea
Purification of ADAMTS13 variants
Lentiviral Modulation of Ror2 and Stat3
According to the manufacturer’s instructions, mBMSCs were infected with lentivirus-based shRNA vector downregulation of Ror2 (sh-Ror2) and lentivirus-based shRNA vector overexpression of Stat3 (sh-Stat3). Briefly, mBMSCs were plated at 1.5 × 104 cells/cm2 in 12-well plates overnight and then infected with lentivirus in the presence of 5 μg/mL polybrene (iGeneBio Biotechnology, Guangzhou, China) for 8 h. After 72 h, mBMSCs infected with sh-Ror2 were selected with 1 μg/mL puromycin (Solarbio, Beijing, China). Those mBMSCs infected with sh-Ror2 and sh-Stat3 were selected with 1 μg/mL puromycin and 50 μg/mL hygromycin B (Solarbio, Beijing, China). The expression of Ror2 and Stat3 was assessed by quantitative real-time polymerase chain reaction (qRT-PCR) and western blot analysis.
Engineered HER2 and HER3 Expression in NIH3T3 and MCF7 Cells
NIH3T3 cells were co-transfected with the wild-type (WT)/S310F-mutant HER2 and HER3 constructs using Lipofectamine 3000 according to the manufacturer’s protocol (Invitrogen, Carlsbad, CA, USA). MCF7 cells were transfected with the WT/S310F-mutant HER2 construct using the above method. For stable ectopic expression, stable WT/S310F-mutant HER2-expressing NIH3T3 cells were selected with Hygromycin B (Solarbio, China) and G418 (Sangon Biotech, China). Stable WT/S310F-mutant HER2-expressing MCF7 cells were selected with Hygromycin B.
Establishing ASPH-Overexpressing HeLa Cells
constructs were first transformed into Top 10 F′ strain (Novagen)
as a propagation host using the calcium chloride transformation method
to make a reserve of the construct. After harvesting GenElute Plasmid
Miniprep (Sigma), the plasmids were linearized utilizing FspI (New England Biolabs) according to the manufacturer’s instructions.
Then, a stable human cervical carcinoma cell line (HeLa) with overexpression
of ASPH on the cell surface (HeLaASPH) was established
using linearized pcDNA3.1/Hygro(+)-ASPH plasmid and TurboFect Transfection
Reagent (Thermo Fisher Scientific) according to the manufacturer’s
instructions, followed by a selection using 200 mg/mL hygromycin B
(Solarbio Science & Technology). Transfection was evaluated by
measuring mRNA (Forward primer: TTGGCGTGGGATACCTCTTG; Reverse primer:
GTCACACTCAGCACCTCTTC) using quantitative RT-PCR and the 2–ΔΔCt method.31 (link) Also, the flow
cytometry analysis of cell surface-displayed ASPH was performed using
FB-50 biotinylated antibody and PE-streptavidin (BioLegend).
Molecular Cloning Reagents Specification
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!